↑Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG (1998). «Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor». Nature377 (6548): 397-404. PMID7566114. doi:10.1038/377397a0.
12Fischle, W; Dequiedt F, Fillion M, Hendzel M J, Voelter W, Verdin E (Sep. de 2001). «Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo». J. Biol. Chem. (United States) 276 (38): 35826-35. ISSN0021-9258. PMID11466315. doi:10.1074/jbc.M104935200.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Stevens, Adam; Garside Helen, Berry Andrew, Waters Charlotte, White Anne, Ray David (mayo. de 2003). «Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735». Mol. Endocrinol. (United States) 17 (5): 845-59. ISSN0888-8809. PMID12569182. doi:10.1210/me.2002-0320.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
12345Zhang, Jinsong; Kalkum Markus, Chait Brian T, Roeder Robert G (Mar. de 2002). «The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2». Mol. Cell (United States) 9 (3): 611-23. ISSN1097-2765. PMID11931768.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
1234Yoon, Ho-Geun; Chan Doug W, Reynolds Albert B, Qin Jun, Wong Jiemin (Sep. de 2003). «N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso». Mol. Cell (United States) 12 (3): 723-34. ISSN1097-2765. PMID14527417.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
12Fischle, Wolfgang; Dequiedt Franck, Hendzel Michael J, Guenther Matthew G, Lazar Mitchell A, Voelter Wolfgang, Verdin Eric (Jan. de 2002). «Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR». Mol. Cell (United States) 9 (1): 45-57. ISSN1097-2765. PMID11804585.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Laherty, C D; Billin A N, Lavinsky R M, Yochum G S, Bush A C, Sun J M, Mullen T M, Davie J R, Rose D W, Glass C K, Rosenfeld M G, Ayer D E, Eisenman R N (Jul. de 1998). «SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors». Mol. Cell (UNITED STATES) 2 (1): 33-42. ISSN1097-2765. PMID9702189.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Masiello, David; Chen Shao-Yong, Xu Youyuan, Verhoeven Manon C, Choi Eunis, Hollenberg Anthony N, Balk Steven P (Oct. de 2004). «Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells». Mol. Endocrinol. (United States) 18 (10): 2388-401. ISSN0888-8809. PMID15256534. doi:10.1210/me.2003-0436.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Song, Liang-Nian; Coghlan Meghan, Gelmann Edward P (Jan. de 2004). «Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor». Mol. Endocrinol. (United States) 18 (1): 70-85. ISSN0888-8809. PMID14593076. doi:10.1210/me.2003-0189.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Cheng, Shinta; Brzostek Sabrina, Lee Suzanne R, Hollenberg Anthony N, Balk Steven P (Jul. de 2002). «Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor». Mol. Endocrinol. (United States) 16 (7): 1492-501. ISSN0888-8809. PMID12089345.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Khan, M M; Nomura T, Kim H, Kaul S C, Wadhwa R, Shinagawa T, Ichikawa-Iwata E, Zhong S, Pandolfi P P, Ishii S (Jun. de 2001). «Role of PML and PML-RARalpha in Mad-mediated transcriptional repression». Mol. Cell (United States) 7 (6): 1233-43. ISSN1097-2765. PMID11430826.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)